[HTML][HTML] Double‐blind, randomized, placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with …

MS Abdallah, AN Ramadan… - CNS neuroscience & …, 2021 - ncbi.nlm.nih.gov
Aims Cilostazol (CLS) has shown antidepressant effect in cardiovascular patients, post‐
stroke depression, and animal models through its neurotrophic and antiinflammatory …

Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major …

MS Abdallah, AN Ramadan… - CNS Neuroscience & …, 2021 - europepmc.org
Aims Cilostazol (CLS) has shown antidepressant effect in cardiovascular patients, post-
stroke depression, and animal models through its neurotrophic and antiinflammatory …

Double‐blind, randomized, placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major …

MS Abdallah, AN Ramadan… - CNS Neuroscience …, 2021 - search.proquest.com
Aims Cilostazol (CLS) has shown antidepressant effect in cardiovascular patients, post‐
stroke depression, and animal models through its neurotrophic and antiinflammatory …

Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major …

MS Abdallah, AN Ramadan, H Omara-Reda… - 2021 - pubmed.ncbi.nlm.nih.gov
Aims Cilostazol (CLS) has shown antidepressant effect in cardiovascular patients, post-
stroke depression, and animal models through its neurotrophic and antiinflammatory …